AI-MIN HUI,Richard Labotka,Neeraj Gupta,Karthik Venkatakrishnan,Guohui Liu
申请号：
US16517963
公开号：
US20190343851A1
申请日:
2019.07.22
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present disclosure relates to methods or dosing regimens comprising a proteasome inhibitor of formula (I), or a pharmaceutically acceptable salt thereof,for treating cancer, or preventing cancer recurrence or progression； wherein ring A, Z1 and Z2 are as defined herein.
